Orange County, California, May 5, 2016 (Newswire.com) - Diagnostic imaging has been on the decline for nearly a decade due to concerns that these tests cause health care costs to spike. However, new advances in the approach to imaging, as well as the adoption of new guidelines are ushering in a new era of medical peripherals that help health care providers cut costs, while helping patients receive better care. Ampronix advanced medical imaging is a renowned authorized reseller of the medical industry’s top brands as well as a world class manufacturer of innovative technology.
EMERGENT POLICY & GUIDELINES
"Ampronix is at the crossroads of this new age. We believe it is imperative to make the best technology at with the lowest possible price point whenever possible."
Jamie Nguyen, Sr. Communications Specialist at Ampronix
Since its introduction to the medical industry, imaging has become an instrumental asset for diagnosis and surgery. In fact, the Harvey L. Neiman Health Policy Institute Report states that it is linked to declines in mortality, longer life expectancy, effective emergency room triage as well as shorter and less hospital visits.
The report also found that cost-cutting policies from 2007 have adversely impacted use of imaging. From 2006 to 2010, Medicare recipients saw a 21 percent drop in costs associated with diagnostic imaging. For privately insured individuals, a 5.4 percent drop was reported from 2009 to 2010.
However, policy changes are not the only cause of imaging utilization reduction. For instance, the Choose Wisely campaign, an initiative by the American Board of Internal Medicine (ABIM), advises patients to engage with their doctors to discuss wasteful or unnecessary medical tests, treatments and procedures.
Their intentions of this campaign are clear––to protect patients. The initiative’s guidelines advise doctors to order tests and procedures only if they are truly necessary and are not duplicative of other tests. U.S. physicians will be obligated to consult guidelines before ordering high-cost diagnostic exams by 2017.
CONCERNS ABOUT RADIATION EXPOSURE
According to U.S. News & World Report Health, current notions about radiation exposure dates back to the 1950s, during the height of the Cold War. Amid concern of nuclear bomb detonation, the Linear No-Threshold model (LNT) was devised. The LNT holds that a person’s risk for developing cancer is directly proportional to their level of radiation exposure.
Dr. James S. Welsh, President of the American College of Radiation Oncology and Dr. Jeffry A. Siegel, President and CEO of Nuclear Physics Enterprises, co-authored the report that argued the LNT model is outdated and is negatively affecting modern medicine.
Since the model was established, new research concerning radiation exposure suggest that cells can heal themselves after low level radiation exposure. They cite evidence that nuclear power plant workers, who are regularly exposed to low level radiation, do not show evidence of higher cancer rates than the general public.
THE SOLUTION
In order to meet the demand of lower radiation exposure and increased patient outcome, health organizations have taken new measures. New guidelines are already in effect to ensure physicians balance cost-effective and quality care.
The use of computerized programming have given physicians the ability to receive immediate feedback as to if they ordered the right test. In addition, new tools that allow radiologists to track their performance have been introduced.
With the advent of precision medicine, a combination of genetics and medical imaging, physicians will be better equipped to understand their patients. 3D optimization and artificial intelligence has also been making waves in the medical community, with clearer imaging making diagnoses more accurate.
"Ampronix is at the crossroads of this new age. We believe it is imperative to make the best technology at with the lowest possible price point whenever possible." Said Jamie Nguyen
Our Modalixx display screens were created so health organizations only need to replace CRT screens instead of entire modalities, allowing clients to both save time and lives.
In addition, our all-in-one Versapaxx display can be used anywhere; angiography lab, operating room or cath lab, among others. The interactive display facilitates advanced analysis by allowing the medical professional to record, edit or zoom.
The effect of shifting industry best practices on medical imaging has been very pronounced in the last decade. As advances in medicine such as molecular imaging and precision medicine are made, Ampronix will be at the forefront of creating the newest necessary medical technology to give medical professionals cost efficient ways of integrating such changes.
Contact Ampronix:
International Sales: +1 949-273-8000
Domestic Sales: 1-800-400-7972 for US and Canada
Email: info@ampronix.com or Contact Us Here
Follow Us:
About Ampronix:
Ampronix is a renowned authorized reseller of the medical industry's top brands as well as a world class manufacturer of innovative technology. Since 1982, Ampronix has been dedicated to meeting the growing needs of the medical community with its extensive product knowledge, outstanding service, and state-of-the-art repair facility. Ampronix prides itself on its ability to offer tailored, one-stop solutions at a faster and more cost effective rate than other manufacturers. Ampronix is ISO 13485:2003, ISO 9001:2008, and ANSI/ESD S20.20-2007 registered and certified.
For more info visit our Homepage
Source: www.Ampronix.com
Share:
